Sunday, July 4, 2021

Covaxin gets nod for trial of booster shot – ET HealthWorld

Hyderabad: Indigenous Covid-19 vaccine Covaxin will now be tested for a booster dose, to be given six months after the second jab.

Bharat Biotech has received the approval of the subject expert committee (SEC) for this. The SEC, which advises the Drugs Controller General of India (DCGI), has recommended that Bharat Biotech conduct the booster dose study only on Phase II trial participants after they have taken 6mcg of Covaxin.

The committee has also directed the company to follow up the subjects for at least for six months after the third dose is administered.

The SEC’s nod for the booster dose study came after Bharat Biotech requested amendments in the approved Phase II trial protocol to allow for administration of a booster dose six months after the second dose.

Follow and connect with us on , Facebook, Linkedin

Source link

Stay Connected


Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...